MX163574B - Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido - Google Patents

Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido

Info

Publication number
MX163574B
MX163574B MX203300A MX20330084A MX163574B MX 163574 B MX163574 B MX 163574B MX 203300 A MX203300 A MX 203300A MX 20330084 A MX20330084 A MX 20330084A MX 163574 B MX163574 B MX 163574B
Authority
MX
Mexico
Prior art keywords
ganglioside
preparing
procedure
pharmaceutical composition
inhalation containing
Prior art date
Application number
MX203300A
Other languages
English (en)
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of MX163574B publication Critical patent/MX163574B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX203300A 1983-11-08 1984-11-06 Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido MX163574B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8349288A IT1212896B (it) 1983-11-08 1983-11-08 Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative

Publications (1)

Publication Number Publication Date
MX163574B true MX163574B (es) 1992-06-02

Family

ID=11270228

Family Applications (1)

Application Number Title Priority Date Filing Date
MX203300A MX163574B (es) 1983-11-08 1984-11-06 Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido

Country Status (22)

Country Link
US (1) US4639437A (es)
EP (1) EP0145209B1 (es)
JP (1) JPS60132920A (es)
KR (1) KR850003503A (es)
AT (1) ATE47035T1 (es)
AU (1) AU569920B2 (es)
BE (1) BE900994A (es)
CH (1) CH662278A5 (es)
DE (1) DE3480053D1 (es)
DK (1) DK160129C (es)
ES (1) ES8608532A1 (es)
FR (1) FR2554346B1 (es)
GR (1) GR80853B (es)
IL (1) IL73292A (es)
IN (1) IN163563B (es)
IT (1) IT1212896B (es)
LU (1) LU85633A1 (es)
MX (1) MX163574B (es)
NO (1) NO844443L (es)
NZ (1) NZ209974A (es)
PT (1) PT79466B (es)
ZA (1) ZA848541B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS6368526A (ja) * 1986-09-11 1988-03-28 Mect Corp シアリルグリセライドからなる神経障害疾患治療剤
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US6407061B1 (en) 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
ATE156704T1 (de) * 1989-12-05 1997-08-15 Ramsey Foundation Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
US5624898A (en) * 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
EP1435972B1 (en) 2001-08-29 2016-03-09 Seneb Biosciences Inc. Novel synthetic ganglioside derivatives and compositions thereof
AU2004220087A1 (en) 2003-03-06 2004-09-23 Seneb Biosciences, Inc. Methods and compositions for the enzymatic synthesis of gangliosides
CU23317A1 (es) 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
EP2410846B1 (en) 2009-03-25 2016-09-07 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262354A (es) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US4094968A (en) * 1972-09-06 1978-06-13 Burroughs Wellcome Co. Treatment for allergy and method of composition thereof
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
DE3480053D1 (en) 1989-11-16
ES537300A0 (es) 1986-07-16
ZA848541B (en) 1985-06-26
IT8349288A0 (it) 1983-11-08
EP0145209A3 (en) 1986-11-26
DK160129C (da) 1991-07-01
NZ209974A (en) 1987-02-20
ATE47035T1 (de) 1989-10-15
IT1212896B (it) 1989-11-30
PT79466A (en) 1984-12-01
FR2554346A1 (fr) 1985-05-10
IL73292A0 (en) 1985-01-31
GR80853B (en) 1985-02-26
EP0145209B1 (en) 1989-10-11
NO844443L (no) 1985-05-09
IL73292A (en) 1988-07-31
US4639437A (en) 1987-01-27
KR850003503A (ko) 1985-06-20
AU3518984A (en) 1985-05-16
JPH0211570B2 (es) 1990-03-14
LU85633A1 (fr) 1985-06-04
DK160129B (da) 1991-02-04
CH662278A5 (fr) 1987-09-30
BE900994A (nl) 1985-05-07
PT79466B (en) 1986-12-12
FR2554346B1 (fr) 1987-11-20
ES8608532A1 (es) 1986-07-16
DK505584D0 (da) 1984-10-23
EP0145209A2 (en) 1985-06-19
AU569920B2 (en) 1988-02-25
DK505584A (da) 1985-05-09
JPS60132920A (ja) 1985-07-16
IN163563B (es) 1988-10-08

Similar Documents

Publication Publication Date Title
MX163574B (es) Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido
UA41906C2 (uk) Спосіб лікування неврологічних порушень, викликаних травмами
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
DE3382641T2 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
ES8306483A1 (es) Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
ZA843489B (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
EP0093497A3 (en) Anthelmintic treatment
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
IT8324141A0 (it) Preparato per la cura delle ustioni.
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
IT1107843B (it) Composizione terapeutica contenente un alcanolo superiore particolarmente per la cura di disturbi secretori prostatici
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
ATE94758T1 (de) Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.
IT8820387A0 (it) Composizioni farmaceutiche comprendenti derivati delglicerolo_3_fosfato atte al trattamento di patologie del sistema nervoso.
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.